Argenx
ARGX
#527
Rank
ยฃ31.57 B
Marketcap
ยฃ526.43
Share price
-2.92%
Change (1 day)
79.18%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -ยฃ3.36

According to Argenx 's latest financial reports the company's current EPS (TTM) is -ยฃ3.42. In 2022 the company made an earnings per share (EPS) of -ยฃ10.78.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ3.36-68.81%
2022-ยฃ10.78